Got a revolutionary healthcare company? Bob Nelsen, Jeff Leiden’s SPAC has $500M to take it public
ARCH Ventures doesn’t hold back when it can go big in biotech VC investments. The same seems to be holding true when it comes to SPACs.
Revolution Healthcare Acquisition, the blank check company ARCH formed in partnership with the tech player General Catalyst, raised the $500 million it asked for in an IPO. The two firms had made it clear that they will be looking to take a digital health company public — with the end goal being part of a paradigm shift involving “technologies like wearable sensors, remote continuous data capture, point of care diagnostics, telehealth capabilities and artificial intelligence/machine learning tools.”
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 157,400+ biopharma pros reading Endpoints daily — and it's free.